⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and The Simply Good Foods Company (NASDAQ: SMPL); Grabar Law Office is Investigating Claims on Your
globenewswire.com
AARD
FTK
GDDY
SMPL
Pomerantz LLP Engages in Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
October 13, 2026 Deadline: Join Class Action Lawsuit Against Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky
accessnewswire.com
AARD
Lost Money on Aardvark Therapeutics, Inc. (AARD)? Urged to Join Class Action Before October 13, 2026 - Contact Levi & Korsinsky
accessnewswire.com
AARD
October 13, 2026 Deadline Approaching: Join Class Action Against Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky
accessnewswire.com
AARD
ROSEN, A LONGSTANDING LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AARD
globenewswire.com
AARD
Pomerantz LLP Announces The Filing of a Class Action Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
AARD STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD
Pomerantz LLP Engages in Class Action Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Class Action Lawsuit Filed: Aardvark Therapeutics, Inc. (AARD) – Join by October 13, 2026 – Contact Levi & Korsinsky
accessnewswire.com
AARD